July 7 (Reuters) - Ucb SA:
* UCB AND FERRING PHARMACEUTICALS ANNOUNCE CO-PROMOTION OF CIMZIA® (CERTOLIZUMAB PEGOL) FOR THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE CROHN’S DISEASE
* FERRING JOINS WITH UCB TO PROMOTE CIMZIA PREFILLED SYRINGE FOR CROHN’S DISEASE IN U.S. Source text for Eikon: Further company coverage: (Gdansk Newsroom)
Our Standards: The Thomson Reuters Trust Principles.